This Small-Cap Biotech Is Turning Heads on Wall Street
Here is how I’m playing a setup in a new name with upcoming catalysts.
Palantir Was One of My Best Trades. Time to Get Back In?
Let’s check the chart, and some promising news, and see if Palantir is ready to roar as it approaches earnings.
New SoFi Price Target as Swing Traders, Portfolio Managers Align
The small-cap financial services firm announced the launch of a new ETF product.
Why I’m Eyeing Lockheed, RTX; Fire in Hormuz; SpaceX Lands on … Nasdaq 100
As U.S.-Iran truce hits bump after ship hit in Hormuz, I’m eyeing adding to these defense stocks; also the latest on NATO, SpaceX and Monday’s market.
2 Setups I’m Trading as Technology Names Are Bouncing
Here’s what’s on my radar and how I’m approaching the trades.
‘Logic’ Tells Me to Buy Lam Research, but Not Yet
LRCX will be a good stock to buy and maybe soon, but not this morning. Here’s how I’d approach this tech winner.
Buying More Ondas Holdings After $875 Million Acquisition News
The small-cap drone firm turned heads on Wall Street with an update on a significant acquisition.
Biotech Stocks Are Surging in 2026. This One Stands Out After a Pullback.
With shares pulling back after a capital raise, this strategy offers double-digit upside potential in addition to downside protection of more than 20%.
Micron Is a Top-3 Stock to Short After Surprise Earnings Response
These three names have shown little interest in rising with the rest of the market.
Is This Strong-Performing Sector About to Roll Over?
I’m reassessing three big winners after an ‘inhospitable’ data point and weakening technicals.